Ritonavir derivate bound to HPMA copolymer carrier has potent antitumor activity which synergizes with IL-2 based immunotherapy

EUROPEAN JOURNAL OF IMMUNOLOGY(2023)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要